Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4472-4478

  Huang, Mingjun ^a,b   Martin, Malcolm A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; GAG PROTEIN; POL PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS GENE; VIRUS PARTICLE;

EID: 0030986290     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4472-4478.1997     Document Type: Article

References (43)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Ansari-Lari, M. A., and R. A. Gibbs. 1996. Expression of human immuno-deficiency virus type 1 reverse transcriptase in trans during virion release and after infection. J. Virol. 70:3870-3875.
3. Ansari-Lari, M. A., L. A. Donehower, and R. A. Gibbs. 1996. Analysis of human immunodeficiency virus type 1 integrase mutants. Virology 211:332-335.
4. Bachelar, L., and H. Fan. 1981. Isolation of recombinant DNA clones carrying complete integrated proviruses of Moloney murine leukemia virus. J. Virol. 37:181-190.
5. Bryant, M., and L. Ratner. 1990. Myristylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87:523-527.
6. Bukovsky, A., and H. Göttlinger. 1996. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J. Virol. 70:6820-6825.
7. Chazal, N., C. Carriere, B. Gay, and P. Boulanger. 1994. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. J. Virol. 68:111-122.
8. Deminie, C. A., and M. Emerman. 1993. Incorporation of human immuno-deficiency virus type 1 Gag proteins into murine leukemia virus virions. J. Virol. 67:6499-6506.
9. Engelman, A., G. Englund, J. M. Orenstein, M. A. Martin, and R. Craigie. 1995. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69:2729-2736.
10. Freed, E. O., and M. A. Martin. 1994. Evidence for a functional interaction between the V1/V2 and CD4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68:2503-2512.
11. Freed, E. O., J. M. Orenstein, A. J. Buckler-White, and M. A. Martin. 1994. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:5311-5320.
12. Gheysen, D., E. Jacobs, F. De Foresta, C. Thiriart, M. Francotte, D. Thines, and M. De Wild. 1989. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112.
13. Göttlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
14. Hansen, M., L. Jelinek, S. Whiting, and E. Barklis. 1990. Transport and assembly of Gag proteins into Moloney murine leukemia virus. J. Virol. 64: 5306-5316.
15. Higuchi, R., B. Krummel, and R. K. Saiki. 1988. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16:7351-7367.
16. Hong, S. S., and P. Boulanger. 1993. Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells. J. Virol. 67:2787-2798.
17. Hsu, H.-W., P. Schwartzberg, and S. P. Goff. 1985. Point mutations in the p30 domain of the gag gene of Moloney murine leukemia virus. Virology 142: 211-214.
18. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:6810-6818.
19. Karacostas, V., K. Nagashima, M. A. Gonda, and B. Moss. 1989. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86:8964-8967.
20. Karacostas, V., E. J. Wolffe, K. Nagashima, M. A. Gonda, and B. Moss. 1993. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193:661-671.
21. Kawai, S., and H. Hanafusa. 1973. Isolation of defective mutants of avian sarcoma virus. Proc. Natl. Acad. Sci. USA 70:3493-3497.
22. Levin, J. G., P. M. Grimley, J. M. Ramseur, and I. K. Berezesky. 1974. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 14:152-161.
23. Loeb, D. D., R. Swanstrom, L. Everitt, M. Manchester, S. E. Stamper, and C. A. Hutchison III. 1989. Complete mutagenesis of the HIV-1 protease. Nature (London) 340:391-400.
24. Mammano, F., Å. Öhagen, S. Höglund, and H. G. Göttlinger. 1994. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68:4927-4936.
25. Mergener, K., M. Facke, R. Welker, V. Brinkmann, H. R. Gelderblom, and H.-G. Krausslich. 1992. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology 186:25-39.
26. Park, J., and C. D. Morrow. 1991. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J. Virol. 65:5111-5117.
27. gag and is incorporated into viruslike particles. J. Virol. 66:6304-6313.
28. Rein, A., M. McClure, N. Rice, R. Luftig, and A. Schultz. 1986. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. USA 83:7246-7250.
29. Ross, E. K., T. R. Fuerst, J. M. Orenstein, T. O'Neill, M. A. Martin, and S. Venkatesan. 1991. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease. AIDS Res. Hum. Retroviruses 7:475-483.
30. Royer, M., S. S. Hong, B. Gay, M. Cerutti, and P. Boulanger. 1992. Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells. J. Virol. 66:3230-3235.
31. gag is excluded from virus assembly and maturation events. J. Virol. 63:2370-2373.
32. Schwartzberg, P., J. Colicelli, M. L. Gordon, and S. P. Goff. 1984. Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase. J. Virol. 49:918-924.
33. Shields, A., O. N. Witte, E. Rothenbert, and D. Baltimore. 1978. High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell 14:601-609.
34. Shin, C.-G., B. Taddeo, W. Haseltine, and C. M. Farnet. 1994. Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J. Virol. 68:1633-1642.
35. gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 64:2743-2750.
36. gag-pol from human immuno-deficiency virus type 1 into virus-like particles. J. Virol. 67:2266-2275.
37. Srinivasakumar, N., M.-J. Hammerskjöld, and D. Rekosh. 1995. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J. Virol. 69:6106-6114.
38. Taddeo, B., W. A. Haseltine, and C. M. Farnet. 1994. Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. J. Virol. 68:8401-8405.
39. von Poblotzki, A., R. Wanger, M. Niedrig, G. Wanner, H. Wolf, and S. Modrow. 1993. Identification of a region in the Pr55gag polyprotein essential for HIV-1 particle formation. Virology 193:981-985.
40. Wang, C.-T., J. Stegeman-Olsen, Y. Zhang, and E. Barklis. 1994. Assembly of HIV Gag-β-galactosidase fusion protein into viras particles. Virology 200:524-534.
41. Willey, R. L., J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner. 1988. Biosynthesis, cleavage and degradation of the human immunodeficiency virus type 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85:9580-9584.
42. Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Moss, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for inactivity. J. Virol. 62:139-147.
43. Wills, J., and R. C. Craven. 1991. Form, function, and use of retroviral gag proteins. AIDS 5:639-654. (Editorial.)